CLINICAL_TRIALS
withdrawal
· 2022-12-12
Clinical Trial Update: Intranasal Lidocaine for Prevention of Postoperative Nausea and Vomiting. [Phase 4]
Summary
A Phase 4 trial of intranasal lidocaine for preventing postoperative nausea and vomiting has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Milton S. Hershey Medical Center | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: WITHDRAWN